1324 Journal of Natural Products, 2009, Vol. 72, No. 7
Notes
to repeated column chromatography over silica gel (CHCl3-MeOH,
30:1; 10:1) and LiChroprep RP-18 eluted with MeOH-H2O (3:2) to
afford compounds 1 (12 mg, 0.00024%) and 2 (8 mg, 0.00016%).
Fraction D was separated by repeated column chromatography over
silica gel (CHCl3-MeOH, 10:1; 5:1) and LiChroprep RP-18 eluted with
MeOH-H2O (1:1) and Sephadex LH-20 eluted with MeOH to afford
compounds 3 (13 mg, 0.00025%) and 4 (5 mg, 0.00010%).
monitoring of UV absorption at 210 and 254 nm. The mobile phase
used was a mixture of MeOH and H2O in which the proportion of
MeOH was increased from 10% to 100% over a 60 min period. The
flow rate was 1.0 mL/min. This resulted in the detection of 1 and 3 in
the EtOAc extract. The retention times of compounds 1-4 were 26.16,
19.21, 17.51, and 16.35 min, respectively.
Assay for Cell-Protective Activities. Evaluation of cell-protective
activities of compounds 1-4 against H2O2-induced PC12 cell damage
was performed according to a protocol reported in the literature.12 Cells
were incubated with 200 µM H2O2 for 30 min, and the cultures were
further developed for another 6 h. Samples were added to the cultures
2 h prior to H2O2 addition. Cell viability was obtained by measuring
MTT reduction. Two independent experiments were carried out in
triplicate. All data were expressed as a percentage of control values.
Statistical comparison was made by using one-way ANOVA and
followed by Duncan’s test. The data were expressed as means ( SEM.
Paeonin A (1): colorless oil; [R]20 -36.5 (c 0.1, pyridine); UV
D
(MeOH) λmax (log ꢀ) 252 (3.84) nm; IR (KBr) νmax 3365, 1679, 1640,
1612 cm-1; 1H NMR (400 MHz, pyridine-d5) and 13C NMR data (100
MHz, pyridine-d5), see Tables 1 and 2; HRESIMS m/z [M + Na]+
395.1286 (calcd for C17H24O9Na, 395.1318).
Paeonin B (2): white, amorphous powder; [R]20 -37.8 (c 0.1,
D
pyridine); UV (MeOH) λmax (log ꢀ) 254 (3.82) nm; IR (KBr) νmax 3360,
1675, 1638, 1610 cm-1; 1H NMR (400 MHz, pyridine-d5) and 13C NMR
data (100 MHz, pyridine-d5), see Tables 1 and 2; HRESIMS m/z [M
+ Na]+ 381.1182 (calcd for C16H22O9 Na, 381.1161).
References and Notes
Paeonin C (3): white, amorphous powder; [R]20 -45.1 (c 0.1,
D
(1) State Administration of Traditional Chinese Medicine. Zhonghuaben-
cao; Shanghai Science and Technology Publishing Company: Shang-
hai, 1999; pp 2104-2105.
(2) Tanaka, T.; Kataoka, M.; Tsuboi, N.; Kouno, I. Chem. Pharm. Bull.
2000, 48, 201–207.
(3) Kostova, I. N.; Simeonov, M. F.; Todorova, D. I.; Petkova, P. L.
Phytochemistry 1998, 48, 511–514.
(4) Murakami, N.; Saka, M.; Shimada, H.; Matsuda, H.; Yamahara, J.;
Yoshikawa, M. Chem. Pharm. Bull. 1996, 44, 1279–1281.
(5) Takagi, K.; Harada, M. Yakugaku Zasshi 1969, 89, 887–890.
(6) Hsu, F. L.; Lai, C. W.; Cheng, J. T. Planta Med. 1997, 63, 323–325.
(7) Watanabe, H. BehaV. Brain Res. 1997, 83, 135–141.
(8) Yoshikawa, M.; Harada, E.; Kawaguchi, A.; Yamahara, J.; Murakami,
N.; Kitagawa, I. Chem. Pharm. Bull. 1993, 41, 630–632.
(9) Shimizu, M.; Hayashi, T.; Morita, N.; Kiuchi, F.; Noguchi, H.; Iitaka,
Y.; Sankawa, U. Chem. Pharm. Bull. 1983, 31, 577–583.
(10) Kostova, I. N.; Simeonov, M. F.; Todorova, D. I. Phytochemistry 1998,
47, 1303–1307.
pyridine); UV (MeOH) λmax (log ꢀ) 256 (3.80) nm; IR (KBr) νmax 3370,
1668, 1650, 1613 cm-1; 1H NMR (400 MHz, pyridine-d5) and 13C NMR
(100 MHz, pyridine-d5), see Tables 1 and 2; HRESIMS m/z [M + Na]+
395.1326 (calcd for C17H24O9Na, 395.1318).
8-Debenzoylpaeonidanin (4): colorless oil; [R]20 -30.2 (c 0.1,
D
pyridine); IR (KBr) νmax 3430, 1700 cm-1
;
1H NMR (400 MHz,
pyridine-d5) and 13C NMR (100 MHz, pyridine-d5), see Tables 1 and
2; HRESIMS m/z [M + Na]+ 413.1398 (calcd for C17H26O10Na,
413.1424).
Hydrolysis of Compounds 1 and 3. Compound 1 (4 mg) was
dissolved in H2O (8 mL) and incubated with almond ꢀ-glucosidase
(20 mg) for 24 h at 37 °C. After general treatment, the sugar moiety
was analyzed by silica gel HPTLC (Merck) developed with Me2CO-2
mM NaOAc (17:3, v/v) and detected by spraying with 0.2% naph-
thoresorcinol in Me2CO-3 N H3PO4 (5:1, v/v), followed by heating at
105 °C for 5 min (Rf 0.53). D-Glucopyranose was used as standard.
The same procedure was used for compound 3.
HPLC Analysis of the EtOAc Extract of P. lactiflora. The EtOAc
extract and compounds 1-4 were analyzed by HPLC using a Zorbax
Extend-C18 (Agilent Technologies) column (4.6 × 250 mm) with
(11) Kim, J. S.; Yean, M. H.; Lee, J. Y.; Kim, Y. J.; Lee, E. J.; Lee, S. Y.;
Kang, S. S. HelV. Chim. Acta 2008, 91, 85–89.
(12) Wang, R.; Xiao, X. Q.; Tang, X. C. Neuroreport 2001, 12, 2629–2634.
NP8001783